!!Stefano Piccolo - Curriculum Vitae \\ __EDUCATION__ \\ *1995 - 1998 HHMI post-doctoral fellow with Prof. Eddy De Robertis, Howard Hughes Medical Institute, University of California, Dept. of Biological Chemistry\\ *1995 PhD in Biology and Pathology of the Connective Tissue; Supervisor: Giorgio Bressan, Institute of Histology and Embryology, University of Padua, School of Medicine, Padua, Italy\\ *1991 Master in Biological Sciences, University of Padua, Italy (score: magna cum laude) \\ __POSITIONS__ \\ *1998 - 2006: Assistant and then (from 2004) Associate Professor in Histology and Embryology, University of Padua, School of Medicine, Padua, Italy.\\ *2006 - present: Full Professor of Molecular Biology, University of Padua School of Medicine\\ *2017 - present: Principal Investigator at IFOM, The FIRC Institute for Molecular Oncology \\ __AWARDS__ \\ *1999 International BIOTECH Award\\ *2003 A. Minich award from Istituto Veneto Scienze, Lettere ed Arti\\ *2005 International Swissbridge Award\\ *2007 Chiara D’Onofrio Award\\ *2011 International Debiopharm Award\\ *2012 International Tartufari award from Accademia Nazionale Lincei\\ *2012 Presidential Venosta award (main cancer Award in Italy) from Fondazione Italiana Ricerca sul Cancro\\ *2015 ERC Advanced Grant\\ *2017 Choh Hao Li Memorial Lectures award \\ __INSTITUTIONAL RESPONSIBILITIES__ \\ *2018 - present: Member of Goverment Board of The Human Technopole Milan\\ *2015 - present: Member of AIRC Scientific Advisory Board \\ *2012 - present: Director PhD program in Molecular Medicine, University of Padua\\ *2004 - 2008: AIRC Grant review panellist\\ \\ COMMISSIONS OF TRUST \\ *2013 - present EMBL Scientific Advisory board (SAC, member) \\ *2012 - 2014 ERC starting and consolidator award (member)\\ *2010 - present Pezcoller Foundation Symposia Scientific Board \\ *2012 and 2017 Pezcoller-AACR Award Committee \\ \\ __MEMBERSHIPS OF SCIENTIFIC SOCIETIES__ \\ \\ *2007 - EMBO member\\ *2014 - Accademia dei Lincei, Rome (Member)\\ *Member of AACR, SIBBM \\ \\ __PATENTS __\\ \\ *2017: "Compounds for somatic stem cell fate control U.S. No. 62,484,566\\ *2015: “Methods for generating somatic stem cells” PCT/EP2015/070305\\ *2011: "Composition for use in treating or preventing cancer”, PCT/EP2010/058495\\ *2010: "Prognosis of Breast Cancer Patients by monitoring two genes” PCT/EP2009/050643 \\ *2007: "TGF-beta modulators and use thereof" PCT/IB2007/000233\\ \\